Aceptabilidad de la vacuna contra el virus del papiloma humano en madres de la provincia de Valencia (España)

Navarro-Illana, Pedro; Caballero, Pablo; Tuells, José; Puig-Barbérà, Joan; Díez-Domingo, Javier

doi:10.1016/j.anpedi.2014.11.018

Cited by 10 publications

(17 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Insufficient knowledge or information, and beliefs that the information available is unclear, biased and/or inadequate were identified in almost all articles reviewed. An average of 44% of hesitant participants from quantitative studies reported that there was insufficient information available about HPV vaccination, and/or that their own knowledge was insufficient, [22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41] particularly in studies in Romania (2015, 81%), 30 the Netherlands (2009-2011, 67%), 26,28 and Denmark (2010, 70%). 35 This was also reported by 53% of general study participants [42][43][44][45][46][47][48][49][50][51] and 11% of favourable study participants.…”

Section: Quantitative Resultsmentioning

confidence: 99%

“…Concerns about the safety of HPV vaccination and potential long-or short-term side effects were reported by an average of 43% of hesitant study participants. [23][24][25][26][27][28][29]31,32,[34][35][36][37][38]40,42,46,49,[70][71][72][73][74][75][76][77][78][79][80][81] Fear of side effects was reported by an average of 52% of general study participants 51,[82][83][84][85][86][87][88][89][90][91][92][93][94][95][96][97] and 17% of favourable study participants. 25,37,71 Concerns about si...…”

Section: Quantitative Resultsmentioning

confidence: 99%

“…While an average of 30% of hesitant parents reported not having received any recommendation to vaccinate from HCWs in studies in Spain (2010-2011), 36 Italy (2012-2015), 29,45,75 Denmark (2010) 35 and France (2015), 29 an average of 26% of hesitant parents in studies from Spain (2010-2011) 36 and Italy (2012-2014) 27,75 were advised not to vaccinate by their HCW. Additionally, 19% of general adolescents in a study from Germany in 2010 reported having been advised not to get the HPV vaccine by their physician.…”

Section: Quantitative Resultsmentioning

confidence: 99%

“…An average of 18% of hesitant study participants 25,26,32,36,37,77,80 were against all vaccines in general. Additionally, 33% of general study participants 90,91 and 28% of hesitant study partici-pants26, 29,35,50,75,80 believed children already receive too many vaccines, with 47% of hesitant parents in a 2015 study in Germany 29 and 46% of hesitant parents in studies in Italy (2007-2015) 29,50,75 raising this concern.…”

Section: Quantitative Resultsmentioning

confidence: 99%

See 3 more Smart Citations

HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe

Karafillakis

Simas

Jarrett

et al. 2019

Human Vaccines & Immunotherapeutics

213

164

View full text Add to dashboard Cite

Europe is increasingly described as the region in the world with the least confidence in vaccination, and particularly in the safety of vaccines. The aim of this systematic literature review was to gather and summarise all peer-reviewed and grey literature published about determinants of Human Papillomavirus (HPV) vaccine hesitancy in Europe. Ten thematic categories were identified across the 103 articles which were included in the review. Participants from European studies most commonly reported issues with the quantity and quality of information available about HPV vaccination; followed by concerns about potential side effects of the vaccine; and mistrust of health authorities, healthcare workers, and new vaccines. Comparative analyses indicated that confidence determinants differed by country and population groups. This evidence supports the need to develop context-specific interventions to improve confidence in HPV vaccination and design community engagement strategies aiming to build public trust.

show abstract

Section: Quantitative Resultsmentioning

confidence: 99%

Section: Quantitative Resultsmentioning

confidence: 99%

Section: Quantitative Resultsmentioning

confidence: 99%

Section: Quantitative Resultsmentioning

confidence: 99%

See 2 more Smart Citations

HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe

Karafillakis

Simas

Jarrett

et al. 2019

Human Vaccines & Immunotherapeutics

213

164

View full text Add to dashboard Cite

show abstract

“…20,21,23,29,30,36,39 Questões como negação da necessidade de vacinação, temor em discutir sobre sexo e DSTs com suas filhas e a preocupação quanto a vacina levar à promiscuidade foram abordadas por pais de todas as nacionalidades, credos e raças. 22,26,27,29,42 A pesquisa atual traz dados diferentes.…”

Section: Discussionunclassified

Motivos para recusa da vacina contra o Papilomavírus Humano entre adolescentes de 11 a 14 anos no município de Maringá-PR

Zanini

Prado

Hendges

et al. 2017

Rev Bras Med Fam Comunidade

View full text Add to dashboard Cite

aReasons for refusal of human papillomavirus vaccine among adolescent girls between 11 and 14 years of age in the municipality of Maringa-PR Introdução: O Ministério da Saúde incluiu a vacina contra o Papilomavírus Humano (HPV) no calendário básico de imunizações em 2014 com a meta vacinar pelo menos 80% das adolescentes entre 11 e 13 anos de idade. Objetivos: Frente à baixa adesão à campanha nacional de vacinação contra o HPV no município de Maringá, PR, em 2014, o presente estudo teve como objetivos: 1) identificar o nível de conhecimento das adolescentes acerca do vírus e da vacina; e 2) descrever os motivos pelos quais elas não se vacinaram. Métodos: Trata-se de um estudo observacional transversal, do tipo inquérito domiciliar com delineamento descritivo, conduzido com 58 adolescentes que não tomaram a 1ª e/ou a 2ª dose da vacina dentro do prazo estipulado pela campanha vacinal de 2014. Para coleta de dados, foi aplicado questionário por meio de entrevistas face a face. Resultados: 86% das adolescentes já ouviram falar do vírus, 74% sabe que sua transmissão é sexual, 49% conhece sua relação com o câncer de colo de útero e 88% já ouviu falar da vacina. A maior parte das meninas entrevistadas não se vacinou por recusa por parte dos pais. Conclusão: Os resultados do presente estudo sugerem que o desconhecimento sobre a infecção pelo HPV e sobre a campanha de vacinação entre as entrevistadas e seus responsáveis, bem como o medo de efeitos colaterais da vacina, como apontado pela população do estudo, interferiram negativamente na tomada de decisão. Introducción: El Ministerio de Salud incluyó la vacuna contra el papiloma humano (VPH) en el calendario básico de vacunación en 2014 con el objetivo de vacunar al menos el 80% de los adolescentes de entre 11 y 13 años. Objetivos: Ante la baja adherencia a la campaña nacional de vacunación contra el virus del VPH en Maringá, estado de Paraná, en 2014, este estudio tuvo como objetivo: 1) identificar el nivel de conocimientos de los adolescentes sobre el virus y la vacuna; y 2) describir las razones por las que no están vacunados. Métodos: Se trata de un estudio transversal observacional, una encuesta domiciliaria con un diseño descriptivo, realizado con 58 adolescentes que no tomaron la primera y/o segunda dosis de la vacuna en el plazo estipulado por la campaña de vacunación de 2014. Para la recolección de datos, se aplicó un cuestionario a través de entrevistas cara a cara. Resultados: 86% de los adolescentes ha oído hablar de los virus, 74% sabe que su transmisión es sexual, 49% conoce su relación con el cáncer cervical y 88% ha oído hablar de la vacuna. La mayoría de las niñas entrevistadas no está vacunada debido al rechazo de los padres. Conclusión: Los resultados de este estudio sugieren que la falta de conocimiento acerca de la infección por VPH y la campaña de vacunación entre los encuestados y sus padres, así como el temor a los efectos secundarios de las vacunas, como se ha señalado por la población de estudio, interfirió negativamente en la toma de decisión. ...

show abstract

Acceptability of two- versus three-dose human papillomavirus vaccination schedule among providers and mothers of adolescent girls: a mixed-methods study in five countries

Islam

Hoyt

Ramos

et al. 2018

Cancer Causes Control

View full text Add to dashboard Cite

Purpose: The World Health Organization revised its HPV vaccination recommendations to include a two (2-) dose schedule for girls aged ≤15 years. We investigated acceptability of 2-versus 3-dose schedule among adolescent vaccination providers and mothers of adolescent girls in five countries. Methods: Adolescent vaccination providers(N=151) and mothers of adolescent girls aged 9-14 years(N=118) were recruited from Argentina, Malaysia, South Africa, South Korea, and Spain. We assessed providers’ preference for a 2-versus 3-dose HPV vaccination schedule via quantitative surveys. Mothers’ attitudes toward a 2-dose schedule were assessed through focus group discussions. Results: Most adolescent providers preferred a 2-over 3-dose HPV vaccination schedule (overall:74%), with preference ranging from 45.2% (South Africa) to 90.0% (South Korea). Lower cost, fewer clinic visits, and higher series completion were commonly-cited reasons for 2-dose preference among providers and mothers. Safety and efficacy concerns were commonly-cited barriers to accepting a 2-dose HPV vaccination schedule among providers and mothers. Mothers generally accepted the reduced schedule, however, requested further information from a trusted source. Conclusions: Adolescent vaccination providers and mothers preferred the 2-dose over 3-dose HPV vaccination schedule. Acceptability of a 2-dose HPV vaccination could be improved with additional information to providers and mothers on HPV vaccination safety and efficacy.

show abstract

Aceptabilidad de la vacuna contra el virus del papiloma humano en madres de la provincia de Valencia (España)

Cited by 10 publications

References 24 publications

HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe

HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe

Motivos para recusa da vacina contra o Papilomavírus Humano entre adolescentes de 11 a 14 anos no município de Maringá-PR

Acceptability of two- versus three-dose human papillomavirus vaccination schedule among providers and mothers of adolescent girls: a mixed-methods study in five countries

Contact Info

Product

Resources

About